Task: Answer the multiple-choice question.
Question: Which compound exhibits a -22.105% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a COC(=O)C(C(=O)OC)C(C[N+](=O)[O-])c1ccc(OC)cc1
b O=C1COc2ccc(-c3csc(NCCc4ccccc4)n3)cc2N1
c O=C(NCc1nc2ccccc2[nH]1)C1=C[C@H](c2ccccc2)C[C@H](OCCCCO)O1
d CC1CCN(S(=O)(=O)N2CCC(C(=O)N3CCC(N(C)CC4CCCO4)CC3)CC2)CC1
e COc1ccccc1C(=O)NC(=O)COC(=O)C1CC2CCCC(C1)C2=O
Answer: d. CC1CCN(S(=O)(=O)N2CCC(C(=O)N3CCC(N(C)CC4CCCO4)CC3)CC2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCN(S(=O)(=O)N2CCC(C(=O)N3CCC(N(C)CC4CCCO4)CC3)CC2)CC1
CC1CCN(S(=O)(=O)N2CCC(C(=O)N3CCC(N(C)CC4CCCO4)CC3)CC2)CC1
[4-[methyl(oxolan-2-ylmethyl)amino]piperidin-1-yl]-[1-(4-methylpiperidin-1-yl)sulfonylpiperidin-4-yl]methanone